CISO Global, Inc.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

CISO$0.17-4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Cash Flows

	Nine Months Ended September 30,
2025 · 2024
Cash flows from operating activities:
Net loss		$(5,857,097)		$(18,723,961)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation - stock options		2,806,800		6,904,141
Stock-based compensation - stock issued for services		438,915		57,900
Non-cash interest expense		9,601,032		274,431
Depreciation and amortization		923,854		1,949,506
Non-cash operating lease costs		125,121		179,124
Bad debt expense		46,627		32,896
Loss on assets held for sale		-		3,189,232
Gain on sale of vCISO		-		(1,000,000)
Change in fair value of derivative liability		(5,467,610)		-
Gain on extinguishment of convertible notes, net		(4,432,434)		-
Other		1,751		117,066
Changes in operating assets and liabilities:
Accounts receivable		492,550		2,334,675
Inventory		-		161,586
Contract assets		(5,013)		(25,355)
Prepaid expenses and other assets		102,381		166,631
Accounts payable and accrued expenses		(4,092,740)		667,381
Lease liabilities		(115,167)		(163,720)
Deferred revenue		(749,012)		295,741
Net cash used in operating activities		(6,180,042)		(3,582,726)
Cash flows from investing activities:
Cash received from sale of vCISO		-		1,000,000
Purchases of property and equipment		-		(83,095)
Net cash provided by investing activities		-		916,905
Cash flows from financing activities:
Proceeds from sales of common stock, net of offering costs		2,816,075		154,947
Proceeds from stock option exercises		2,792		-
Proceeds from exercises of warrants		1,547,999		-
Proceeds from loans payable		-		4,273,823
Proceeds from convertible notes payable		5,000,000		-
Proceeds from line of credit		12,685,125		2,564,589
Payments on line of credit		(12,681,002)		(466,555)
Payments on loans payable		(1,663,165)		(4,277,125)
Payments of debt issuance costs		(1,408,642)		(144,000)
Net cash provided by financing activities		6,299,182		2,105,679
Effect of exchange rates on cash and cash equivalents		-		(59,214)
Net increase (decrease) in cash and cash equivalents		119,140		(619,356)
Cash and cash equivalents - beginning of the period		992,589		1,062,442
Cash and cash equivalents - end of the period		$1,111,729		$443,086
Reconciliation of cash and cash equivalents:
Cash and cash equivalents from continuing operations		$1,111,729		$443,086
Cash and cash equivalents included in assets of business held for sale		-		-
Total cash and cash equivalents, end of period		$1,111,729		$443,086
Supplemental cash flow information:
Cash paid for:
Interest		$646,059		$1,780,035
Income taxes	$	-	$	-
Supplemental disclosures of non-cash investing and financing activities:
Common stock issued in exchange for services		$438,915	$	-
Common stock issued as a lending discount	$	-		$122,000
Conversion of convertible notes - common stock		$8,988,669	$	-
Conversion of convertible notes - preferred stock		$4,001,698	$	-

The accompanying notes are an integral part of these condensed consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.